Nutriflex Omega Special

Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine and Threonine, the active ingredients in Nutriflex Omega Special, constitute an essential amino acid mixture presented as a sterile solution for intravenous use. It is employed to support protein synthesis and nitrogen balance in adult and pediatric patients who cannot receive enteral nutrition.

GNH USA supplies Nutriflex Omega Special as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide, including tertiary care centers and specialty nutrition units through established distribution networks.

Nutriflex Omega Special provides an amino acid solution that supports the parenteral nutrition pathway in various clinical settings.

Critical care patients: helps meet protein and nitrogen requirements when oral intake is insufficient. Post‑operative recovery: supplies essential amino acids to promote wound healing and lean body mass restoration. Severe malnutrition: provides a balanced amino acid profile for patients unable to tolerate enteral feeding. Renal replacement therapy patients: delivers amino acids while allowing individualized electrolyte management.

Nutriflex Omega Special may be associated with the following adverse reactions, reported in clinical use of intravenous amino acid solutions.

Common Side Effects: - Hyperglycemia: transient increase in blood glucose levels. - Nausea or vomiting: mild gastrointestinal discomfort. - Infusion site irritation: erythema or pain at the catheter. - Mild headache: transient cephalic discomfort.

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity requiring immediate intervention. - Metabolic acidosis: significant pH decline due to amino acid metabolism. - Renal failure: acute deterioration of kidney function in susceptible patients. - Thrombophlebitis: inflammation and clot formation in the infused vein.

When using Nutriflex Omega Special, clinicians should observe the following precautions to ensure patient safety. - Renal impairment: monitor serum creatinine and adjust infusion rate. - Hepatic dysfunction: assess liver enzymes and consider reduced amino acid load. - Electrolyte disorders: correct potassium, calcium and magnesium abnormalities before administration. - Hyperglycemia risk: check blood glucose regularly, especially in diabetic patients. - Pregnancy and lactation: use only if clearly indicated after risk‑benefit evaluation. - Store at ambient temperature: keep in original container, protect from moisture and light.

Nutriflex Omega Special can interact with other medicines; awareness of the following interactions is recommended.

Major Interactions (Avoid): - High‑dose potassium supplements: may cause dangerous hyperkalemia when combined. - Loop diuretics (e.g., furosemide): increase risk of electrolyte depletion during infusion.

Moderate Interactions (Monitor Closely): - Insulin therapy: amino acid infusion can affect glucose control, requiring dose adjustment. - Corticosteroids: may enhance protein catabolism, altering the intended anabolic effect. - Other parenteral nutrition components (lipid emulsions, dextrose solutions): potential incompatibility leading to precipitation. - Anticoagulants (heparin): monitor coagulation parameters as amino acids may influence platelet function.